Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari
HSE National Procedure

HSE National Procedure on Nirsevimab to reduce RSV and associated hospitalisations in Infants


Topic: Respiratory syncytial virus (rsv), Immunisation
Document Owner: National clinical programme for paediatrics and neonatology, national women and infants health programme
National Group: National women and infants health programme
Effective From: 11 September 2024
This Standard Operating Procedure (SOP) has been developed to support Clinicians in the implementation of the respiratory syncytial virus (RSV) Immunisation Pathfinder Programme.

The SOP is for clinicians and seeks to provide direction, information and support for Midwives, Nurses, Pharmacists/Pharmaceutical Technicians, Neonatologists, and Paediatricians working in Maternity Hospitals/ Units, Neonatal Units and Paediatric settings.